Kazia Therapeutics Ltd (KZIA) stock
KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
$5.49+0.18 (+3.39%)
Close on Nov 18, 2026Market cap $8.89MP/E –Yield –
Kazia Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Kazia Therapeutics's total assets was A$71.11M at Dec 31, 2025. For fiscal 2025 it was A$6.06M, down 71.9% from the year before. The highest annual figure on record is A$57.09M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | A$6.06M | -71.9% |
| FY2024 | Jun 30, 2024 | A$21.59M | -23.1% |
| FY2023 | Jun 30, 2023 | A$28.08M | -21.7% |
| FY2022 | Jun 30, 2022 | A$35.89M | -37.1% |
| FY2021 | Jun 30, 2021 | A$57.09M | +147.6% |
| FY2020 | Jun 30, 2020 | A$23.06M | +8.9% |
| FY2019 | Jun 30, 2019 | A$21.18M | -24.8% |
| FY2018 | Jun 30, 2018 | A$28.18M | -21.5% |
| FY2017 | Jun 30, 2017 | A$35.91M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | A$71.11M | +191.6% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | A$6.06M | -78.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | A$17.91M | -35.7% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | A$21.59M | -39.9% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | A$24.38M | -57.3% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | A$28.08M | +21.8% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | A$27.84M | +31.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | A$35.89M | +27.4% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | A$57.09M | +59.0% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | A$23.06M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | A$21.18M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | A$28.18M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | A$35.91M | – |
See a number that looks wrong?